Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00520-020-05493-y.

Title:
Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma | Supportive Care in Cancer
Description:
Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Dating & Relationships

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, myeloma, pubmed, multiple, google, scholar, patients, cancer, life, quality, symptom, cas, study, rrmm, anderson, healthrelated, oncol, relapsed, clin, burden, refractory, outcomes, clinical, review, care, wang, dexamethasone, httpsdoiorgjco, van, central, impact, cleeland, patientreported, symptoms, access, haematol, bortezomib, privacy, cookies, content, data, symptomatic, orlowski, treatment, survival, med, httpsdoiorgjx, information, publish, research,

Topics {✒️}

month download article/chapter org/professionals/physician_gls/pdf/myeloma relapse/refractory multiple myeloma assess clinical decision-making population-based profiles registry relapsed/refractory multiple myeloma mapping eortc qlq-c30 gov/statfacts/html/mulmy patient-reported outcomes real-world treatment patterns article supportive care anderson symptom inventory health/national cancer institution araceli garcia-gonzalez & charles rrmm-related symptoms burden full article pdf refractory multiple myeloma van der holt melphalan refractory myeloma siegel ds privacy choices/manage cookies describe symptom burden high symptom burden related subjects relapsed multiple myeloma van de velde araceli garcia-gonzalez single-center experience placebo-controlled trial stable multiple myeloma stewart ak individual participants included describe symptom trajectory assessing symptom distress bristol-myers squibb bmc cancer 16 recombinant human erythropoietin oral ixazomib global clinical management health-related quality health-related quality high symptoms burden multiple myeloma patients advanced multiple myeloma author information authors de la loge cleeland cs article kamal symptom research european economic area

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma
         description:Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
         datePublished:2020-05-11T00:00:00Z
         dateModified:2020-05-11T00:00:00Z
         pageStart:467
         pageEnd:475
         sameAs:https://doi.org/10.1007/s00520-020-05493-y
         keywords:
            Multiple myeloma
            Refractory
            Patient-reported outcomes
            Quality of life
            Symptom burden
            Functional outcomes
            Oncology
            Nursing
            Nursing Research
            Pain Medicine
            Rehabilitation Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00520-020-05493-y/MediaObjects/520_2020_5493_Fig1_HTML.png
         isPartOf:
            name:Supportive Care in Cancer
            issn:
               1433-7339
               0941-4355
            volumeNumber:29
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mona Kamal
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:Ain Shams University
                     address:
                        name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Shelley Wang
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Qiuling Shi
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teresa M. Zyczynski
               affiliation:
                     name:Bristol-Myers Squibb
                     address:
                        name:Bristol-Myers Squibb, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Catherine Davis
               affiliation:
                     name:Bristol-Myers Squibb
                     address:
                        name:Bristol-Myers Squibb, Princeton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Loretta A. Williams
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hui-Kai Lin
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Araceli Garcia-Gonzalez
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charles S. Cleeland
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert Orlowski
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma
      description:Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of life in RRMM patients. The cross-sectional study included 184 MM patients (141 RRMM cases and 43 MM patients on follow-up without diagnosis/treatment of RRMM disease as controls), while 64 RRMM patients also provided longitudinal patient-reported outcomes (PROs) data. Symptomatic status was based on clinical measures of disease activity. PROs included the MD Anderson Symptom Inventory multiple myeloma module (MDASI-MM), single-item quality of life (SIQOL), and EuroQol-5D (EQ-5D). Wilcoxon rank test and effect size were used for comparisons. Regression models were used to describe symptom trajectory and to identify predictors of high symptom burden during 3 months of RRMM therapy. Most patients were clinically identified as symptomatic (93%). RRMM patients tended to report more severe symptoms, with significantly lower QOL scores and more severe fatigue, poor appetite, and lower enjoyment of life compared with controls (all p < 0.05). In RRMM patients, lower hemoglobin and higher B-2 microglobulin levels significantly correlated with higher burdens of fatigue, pain, and muscle weakness and also with lower QOL and EQ-5D scores (all p < 0.05). During RRMM therapy, being female, with any comorbidity, ≥ 65 years old, and ≥ 5 years MM history, contributed to high symptoms burden and poor QOL status (each p < 0.05). MDASI-MM modules were sensitive to detect the RRMM-related symptoms burden, which correlated with objective clinical measures. RRMM patients reported a more compromised QOL.
      datePublished:2020-05-11T00:00:00Z
      dateModified:2020-05-11T00:00:00Z
      pageStart:467
      pageEnd:475
      sameAs:https://doi.org/10.1007/s00520-020-05493-y
      keywords:
         Multiple myeloma
         Refractory
         Patient-reported outcomes
         Quality of life
         Symptom burden
         Functional outcomes
         Oncology
         Nursing
         Nursing Research
         Pain Medicine
         Rehabilitation Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00520-020-05493-y/MediaObjects/520_2020_5493_Fig1_HTML.png
      isPartOf:
         name:Supportive Care in Cancer
         issn:
            1433-7339
            0941-4355
         volumeNumber:29
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mona Kamal
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:Ain Shams University
                  address:
                     name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Shelley Wang
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Qiuling Shi
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teresa M. Zyczynski
            affiliation:
                  name:Bristol-Myers Squibb
                  address:
                     name:Bristol-Myers Squibb, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Catherine Davis
            affiliation:
                  name:Bristol-Myers Squibb
                  address:
                     name:Bristol-Myers Squibb, Princeton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Loretta A. Williams
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hui-Kai Lin
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Araceli Garcia-Gonzalez
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charles S. Cleeland
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert Orlowski
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Supportive Care in Cancer
      issn:
         1433-7339
         0941-4355
      volumeNumber:29
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Ain Shams University
      address:
         name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Bristol-Myers Squibb
      address:
         name:Bristol-Myers Squibb, Princeton, USA
         type:PostalAddress
      name:Bristol-Myers Squibb
      address:
         name:Bristol-Myers Squibb, Princeton, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mona Kamal
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:Ain Shams University
            address:
               name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
               type:PostalAddress
            type:Organization
      name:Xin Shelley Wang
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Qiuling Shi
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Teresa M. Zyczynski
      affiliation:
            name:Bristol-Myers Squibb
            address:
               name:Bristol-Myers Squibb, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Catherine Davis
      affiliation:
            name:Bristol-Myers Squibb
            address:
               name:Bristol-Myers Squibb, Princeton, USA
               type:PostalAddress
            type:Organization
      name:Loretta A. Williams
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Hui-Kai Lin
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Araceli Garcia-Gonzalez
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Charles S. Cleeland
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Robert Orlowski
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Clincal Oncology, Ain Shams University, Cairo, Egypt
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Bristol-Myers Squibb, Princeton, USA
      name:Bristol-Myers Squibb, Princeton, USA
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(174)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.99s.